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According to previous reports, adjuvant-induced arthritic rats present reduced activities of the hepatic glucose 6-phosphatase. A kinetic
study was done in order to characterize this phenomenon. Microsomes were isolated from livers of arthritic and control rats (Holtzman strain)
and the glucose 6-phosphatase was measured at various temperatures (13–37 jC) and glucose 6-phosphate concentrations. Irrespective of the
temperature, the enzyme from arthritic rats presented a reduction of both Vmax and KM. Detergent treatment of liver microsomes from control
rats increased the activity, but no increase was found when microsomes from arthritic rats were treated in the same way. The mannose 6-
phosphatase activity of detergent-treated microsomes from arthritic rats was only 25% of the activity found with detergent-treated
microsomes from control rats. Without detergent treatment, the mannose 6-phosphatase activities of both control and arthritic rats were
minimal. The activation energy, derived from Vmax, was not changed by arthritis. In vivo arthritic rats presented higher hepatic glucose 6-
phosphate concentrations, a phenomenon that is consistent with a reduced activity of glucose 6-phosphatase. It was concluded that in arthritic
rats, the hydrolase is probably reduced, without a similar change in the translocase activity.D 2003 Elsevier Science B.V. All rights reserved.Keywords: Adjuvant-induced arthritis; Liver; Microsome; Glucose 6-phosphatase; Kinetics1. Introduction
The adjuvant-induced arthritis is an experimental immu-
nopathology in rats that shares many features of human
rheumatoid arthritis [1]. For this reason, it is one of the most
widely used models for evaluation of anti-inflammatory and
antirheumatic drugs [2,3]. Besides this utility, adjuvant-
induced arthritic rats present many metabolic alterations that
are possibly similar to those found in humans with rheuma-
toid arthritis. Carbohydrate metabolism, for example, seems
to be substantially affected in arthritic rats, as shown by
recent experiments. Gluconeogenesis from a variety of
substrates is reduced [4,5], whereas glycolysis from exoge-
nous glucose is enhanced in livers from arthritic rats [6]. The
latter phenomenon seems to be the consequence of an
enhanced capacity of glucose phosphorylation in the liver
of arthritic rats. The available kinetic parameters allow to0925-4439/03/$ - see front matter D 2003 Elsevier Science B.V. All rights reserv
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E-mail address: abracht@uem.br (A. Bracht).estimate that, for the physiological glucose concentration of
5 mM, the velocity of phosphorylation in the liver of arthritic
rats can be expected to exceed that one in the controls by a
factor of 2.7 [6].
Based on the example of glucokinase and considering the
arthritis-induced modifications in gluconeogenesis and gly-
colysis, it looks plausible that the activities of several
enzymes participating in carbohydrate metabolism are
changed in the liver of arthritic rats. One such enzymatic
activity seems to be glucose 6-phosphatase, as can be
deduced from a preliminary report, which suggests a reduc-
tion in the activity of this enzyme [7]. Glucose 6-phosphatase
is a membrane-bound enzyme, a class of enzymes that seems
particularly sensitive to the adjuvant disease, as can be judged
from the fact that many microsomal drug metabolizing
enzymes are affected [8,9]. Glucose 6-phosphatase presents
a complex molecular organization. According to the domi-
nant view, it consists of an unspecific phosphatase, with its
catalytic site oriented towards the lumen of the endoplasmic
reticulum [10–12]. A translocase, which is specific for
glucose 6-phosphate, catalyses the transfer of this metaboliteed.
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work, we are presenting a detailed experimental analysis of
the alterations caused by the adjuvant-induced arthritis in the
kinetic properties of glucose 6-phosphatase. The work has
two main purposes: (a) to obtain kinetic parameters that will
allow to predict and interpret the behaviour of glucose 6-
phosphatase under specific experimental conditions in intact
cell systems; (b) to gain at least a previous idea about the
mechanism of the changes caused by arthritis. This should be
an initial step in the direction of a more precise understanding
of the enzyme’s role in the metabolic alterations that occur in
the liver of arthritic rats.2. Materials and methods
2.1. Materials
Glucose 6-phosphate, mannose 6-phosphate, glucose 6-
phosphate dehydrogenase and NADP+ were purchased from
Sigma Chemical Co. (St Louis, USA). All other chemicals
were from the best available grade (98–99.8% purity) and
were purchased from Merck (Darmstadt, FRG), Carlo Erba
(Sa˜o Paulo, Brazil) and Reagen (Rio de Janeiro, Brazil).
2.2. Animals and treatments
Male Holtzman rats, weighing 180–250 g, were fed ad
libitum with a standard laboratory diet (PurinaR, Sa˜o Paulo,
Brazil). For the induction of adjuvant arthritis, the animals
were injected in the left hind paw with 100 Al of Freund’s
adjuvant (heat inactivated Mycobacterium tuberculosis,
derived from human strains H37Rv), suspended in mineral
oil at a concentration of 0.5% (w/v). Animals showing the
characteristic lesions after 15 days of adjuvant injection
were selected for the experiments [13]. Rats of similar ages
(60 days) were injected with mineral oil and served as
controls. Fasted rats are animals from which food was
withdrawn 24 h prior to the experiments. All experiments
were approved by the Animal Experiments Ethics Commit-
tee of the University of Maringa´.
2.3. Microsome isolation
Microsomes were isolated by differential centrifugation
[14]. The rats were decapitated, the livers excised, cut in
small pieces with scissors and washed with a cold (4 jC)
aqueous solution containing 250 mM sucrose, 2.5 mM N-2-
hydroxyethylpiperazine-NV-2-ethane-sulfonic acid (HEPES;
pH 7.4) and 5 mM ethylenediamine tetraacetate (EDTA).
Homogenization was done with a van Potter-Elvehjem
homogenizer. The homogenate was filtered through gaze
and centrifuged at 2500 g during 10 min in a refrigerated
centrifuge. The supernatant was collected and centrifuged at
17000 g during 20 min. The supernatant of this centrifu-
gation step was again centrifuged at 105000 g for 1 h.The pellet, containing the microsomal fraction, was sus-
pended in cold medium (4 jC) containing 250 mM sucrose
and 2.5 mM HEPES (pH 6.8). The volume was adjusted so
as to achieve a protein concentration of 10 mg/ml. The
protein content was measured by the method of Lowry et al.
[15], using bovine serum albumin as a standard.
2.4. Glucose 6-phosphatase assay
The glucose 6-phosphatase activity was assayed by meas-
uring phosphate release after 10 min of incubation of the
microsomal fraction in the presence of substrate according to
the procedure described by Baginski et al. [16]. The incuba-
tion medium was that one described by Moore et al. [17]: 0.1
M KCl, 10 mM MgCl2, 80 mM tris(hydroxymethyl)amino-
methane (TRIS; pH 6.5). The glucose 6-phosphate concen-
tration was varied in the range between 0.19 and 34 mM and
the microsomal protein concentration between 0.5 and 2 mg/
ml. The reaction was initiated by the addition of glucose 6-
phosphate, after temperature equilibration. Assays were done
at four different temperatures: 13, 20, 30 and 37 jC. The
enzyme activity was expressed as nanomoles phosphate
released per minute per milligram of protein. When required,
glucose 6-phosphate was replaced by mannose 6-phosphate,
at a concentration of 1.6 mM.
In a series of assays, the microsomes were previously
treated with Triton X100R. Approximately 10 mg of micro-
somal protein were suspended in 1.1 ml of a solution
containing 0.67 mM 3-(N-morpholine)propanesulfonic acid
(MOPS, pH 7.4) and 0.77 mg/ml Triton X100R. After
vigorous shaking for 1 min, the mixture was kept in ice bath
for 10 min before the assays. For the assays, aliquots were
transferred to the incubation medium for final protein con-
centrations between 0.5 and 1 mg/ml. The composition of the
incubation medium was that one described above except that
it contained 80 Ag/ml Triton X100R. For the control assays,
microsomes (c 10 mg protein/ml) were suspended in 0.67
mMMOPS (pH 7.4) solution without Triton X100R, shaken
for 1 min and kept in ice bath for 10 min before use.
2.5. Hepatic glucose 6-phosphate levels
The hepatic content of glucose 6-phosphate was deter-
mined by an enzymatic procedure using yeast glucose 6-
phosphate dehydrogenase according to Lang and Michal
[18]. The rats were anesthetized by i.p. injection of sodium
pentobarbital (50 mg/kg). An excision was made in the
abdomen and one lobe of the liver was excised and
immediately frozen in liquid nitrogen. The powdered tissue
was extracted twice with 2 M perchloric acid and centri-
fuged. The extract was neutralized with potassium carbonate
and triethanolamine. After precipitation of the potassium
perchlorate, the supernatant, with pH between 7 and 7.5,
was used for the assay. The assay system contained 1 mM
NADP+, 5 mM MgCl2, 50 mM triethanolamine (pH 7.6)
and glucose 6-phosphate dehydrogenase. The increase in
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formed in concentration (e = 6.22 mM 1 cm 1).
2.6. Calculations
Reaction rates (v) versus glucose 6-phosphate concen-
tration (CG6P) relationships were analysed in terms of the
Michaelis–Menten equation:
v ¼ VmaxCG6P
KM þ CG6P ð1Þ
The maximal reaction rates (Vmax) and the Michaelis–
Menten constants (KM) were computed by fitting Eq. (1)
to the experimental data. A nonlinear iterative least-squares
procedure was utilized [19].
Maximal reaction rates (Vmax) versus inverse absolute
temperature relationships were analysed in terms of the
Arrhenius equation in its logarithmic form [20]:





In Eq. (2), T represents the absolute temperature (Kelvin), R
is the universal gas constant (1.99 cal mol 1 deg 1) and Ea
is the activation energy of the catalysed reaction (cal mol 1).
Eq. (2) was fitted to the experimental ln Vmax versus 1/T
relationships by means of a least-squares procedure.Fig. 1. Reaction rate of hepatic glucose 6-phosphatase from control and
arthritic rats in the fasted (A) and fed (B) states as a function of glucose 6-
phosphate concentration. The enzymatic activity was measured at 37 jC as
described in Materials and methods. The experimental points are the
meansF S.E. of 3–13 determinations. The continuous lines were calculated
by means of the Michaelis–Menten equation (Eq. (1)) with optimized values
for KM and Vmax. These parameters were optimized by means of a nonlinear
least-squares procedure. Their valuesF S.E. were: (a) fasted control,
KM= 3.61F 0.11 mM and Vmax = 343.6F 3.26 nmol min
 1 mg 1; (b)
fasted arthritic, KM= 1.41F 0.13 mM and Vmax = 104.7F 3.65 nmol min
 1
mg 1; (c) fed control, KM= 3.79F 0.22 mM and Vmax = 261.5F 5.33 nmol
min 1 mg 1; (d) fed arthritic, KM= 0.79F 0.06 mM and Vmax = 83.2F1.89
nmol min 1 mg 1.3. Results
The results of initial rate measurements as a function of
glucose 6-phosphate concentration are illustrated by the
graphs in Fig. 1, which show data obtained at 37 jC. Panel
A shows the mean results plus mean standard errors
obtained with the enzyme from fasted rats (24 h) and panel
B the corresponding data obtained with the enzyme from fed
rats. The rates were normalized by expressing them as nmol
min 1 (mg protein) 1. For the controls, the glucose 6-
phosphatase activity was higher in the fasted state. The most
prominent difference, however, was that one between the
control and arthritic conditions. For the latter, the glucose 6-
phosphatase activity was clearly below that of the controls
for most glucose 6-phosphate concentrations. It is apparent,
however, that the enzyme from arthritic rats saturates at
lower substrate concentrations when compared with the
enzyme from control rats. Especially in the fed state, the
reaction rates of the enzymes from control and arthritic rats
are very similar for glucose 6-phosphate concentrations up
to 1 mM. This characteristic is fully confirmed by the
kinetic parameters, KM and Vmax, obtained by fitting the
Michaelis–Menten equation (Eq. (1)) to the experimental
data. The continuous lines in Fig. 1 represent the theoretical
curves that were calculated by means of Eq. (1), using the
kinetic parameters given in the legend to Fig. 1. As can bejudged visually, agreement between theory and experiment
was good. The goodness of the fitting procedure is further
corroborated by the low mean standard errors of the fitted
parameters, which are also given in the legend to Fig. 1.
Analysis of the Vmax values reveals that they were strongly
reduced in the arthritic state: 69.5% in the fasted state and
68.1% in the fed state. The KM values, however, were also
reduced: 60.9% in the fasted state and 79.1% in the fed
state. Glucose 6-phosphatase was also measured in whole
liver homogenates of fasted rats. An activity of 95 nmol
min 1 (mg protein) 1 was found in liver homogenates of
control rats, whereas 47 nmol min 1 (mg protein) 1 were
Fig. 2. Arrhenius representations of ln Vmax versus reciprocals of the
absolute temperature (1/T). The Vmax values at the four different temper-
atures (13, 20, 30 and 37 jC) were obtained from experiments similar to
those illustrated by Fig. 1A,B by fitting the Michaelis–Menten equation to
the data. At each temperature, 3–13 reaction rates versus concentration
experiments were done. A nonlinear least-squares procedure was used. The
straight lines in panels A and B represent the regression line obtained by
fitting the Arrhenius equation to the experimental data (Eq. (2)). The
following values for Ea (activation energy)F S.E. were obtained: fasted
control, 11.41F 2.43 kcal mol 1; fasted arthritic, 10.18F 3.09 kcal
mol 1; fed control, 13.10F 0.80 kcal mol 1; fed arthritic, 12.70F 2.11
kcal mol 1.
Fig. 3. Reaction rate of hepatic glucose 6-phosphatase from control (A) and
arthritic rats (B) in the fed state as a function of glucose 6-phosphate
concentration, before and after Triton X100R treatment. Triton X100R
treatment and measurement of the enzymatic activity were done at 13 jC as
described in Materials and methods. The experimental points are the means
of three determinationsF S.E. The continuous lines were calculated by
means of the Michaelis–Menten equation (Eq. (1)) with optimized values
for KM and Vmax. These parameters were optimized by means of a nonlinear
least-squares procedure. Their valuesF S.E. were: (a) control/no treatment,
KM= 3.66F 0.41 mM and Vmax = 40.1F1.46 nmol min
 1 mg 1; (b)
control/Triton X100R treatment, KM = 1.29F 0.21 mM and Vmax =
52.9F 2.31 nmol min 1 mg 1; (c) arthritic/no treatment, KM= 0.35F
0.06 mM and Vmax = 16.8F 0.6 nmol min
 1 mg 1; (d) arthritic/Triton
X100R, KM= 0.22F 0.03 mM and Vmax = 15.2F 0.39 nmol min
 1 mg 1.
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between the control and arthritic conditions revealed by
the graphs in Fig. 1 are thus not an artifact arising during
microsome isolation.
Fig. 2 shows the relation between the Vmax values and
temperature in the range between 13 and 37 jC. Actually,
the natural logarithms of the Vmax values, obtained by fitting
Eq. (1) to the experimental data, were represented against
the reciprocal absolute temperature (Kelvin). This allows
analysis of the data in terms of the Arrhenius equation (Eq.
(2)) by means of linear correlation. A centigrade temper-
ature scale, however, is also given on the top of each graph.
Fig. 2 reveals different Vmax values between the control andthe arthritic condition for the entire temperature range. The
straight lines in Fig. 2 were calculated according to Eq. (2)
using the optimized parameters. It is apparent that the slopes
of these straight lines are similar, a fact that reflects in the
activation energies (Ea) obtained for each condition. These
activation energies are listed in the legend to Fig. 2 in
addition to the corresponding mean standard errors. Ea
values between 10.2 and 13.1 kcal mol 1 were obtained.
There is a tendency toward higher values in the fed state, but
statistical significance is lacking.
Table 2
Glucose 6-phosphate contents in livers of control and arthritic rats in the fed




[Amol (g liver) 1]
Arthritic
[Amol (g liver) 1]
Fasted (24 h) 0.061F 0.013a (n= 6) 0.253F 0.017a (n= 6)
Fed 0.329F 0.026b (n= 4) 0.471F 0.017b (n= 4)
Values are meansF S.E.
a Student’s t test: P < 0.001.
b Student’s t test: P< 0.01.
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differently upon Triton X100R treatment, as illustrated by
Fig. 3. When microsomes are treated by Triton X100R in the
way described in Materials and methods, their membranes
become fully permeable to glucose 6-phosphate and other
substances, so that the translocase activity is no longer
limiting the hydrolytic activity [10,12]. As expected from
previous reports, Triton X100R treatment of microsomes
from control animals resulted in activation of glucose 6-
phosphate hydrolysis (panel A). When microsomes of
arthritic animals were treated in the same way, however, no
such stimulation took place (panel B). It should be noted that
the scales in panels A and B are different. The rate scale (v)
was expanded in panel B because the glucose 6-phosphatase
activity in arthritic rats was lower. The saturation curves in
Fig. 3 were also analysed in terms of the Michaelis–Menten
equation. The continuous curves are the theoretical ones,
calculated with the optimized parameters given in the legend
to Fig. 3. For the enzyme from control rats, the Vmax was
increased (by 31%), but the KM was decreased (by 74.7%).
For the enzyme from arthritic rats, on the other hand, the Vmax
was not significantly changed, with a smaller decrease in the
KM value (37.1%). It is worth to mention that the Vmax/KM
ratio, which can be taken as an indicator for catalytic
efficiency [19], was equal to 0.011 ml min 1 (mg protein) 1
in the control condition and was increased to 0.041ml min 1
mg 1 upon Triton X100R treatment. A much smaller change
of the Vmax/KM ratio was found in the arthritic condition: it
was equal to 0.048 ml min 1 mg 1 before treatment and
became equal to 0.069 ml min 1 mg 1 after treatment.
Hydrolysis of mannose 6-phosphate was minimal when
microsomes of both control and arthritic rats were incubated
without Triton X100R, as revealed by Table 1. As expected,
after Triton X100R treatment, the mannose 6-phosphate
hydrolysis increased considerably in both fed and fasted
states (treated nontreated values of 21.1 and 18.5 nmol
min 1 mg 1, respectively). Treatment of microsomes from
arthritic rats also produced increases in mannose 6-phos-
phate hydrolysis. The changes, however, were only one
fourth of those ones observed with the enzyme from control
rats (treated nontreated values of 4.0 and 4.4 nmol min 1
mg 1, respectively).
To gain at least some preliminary information about the
physiological significance of the changes described above,Table 1
Mannose 6-phosphatase activities of microsomes from control and arthritic






(nmol min 1 mg 1)
Control Arthritic
Fed Triton X100R 0.40F 0.16 (n= 3) 1.10F 0.17 (n= 5)
+ Triton X100R 21.5F 3.05 (n= 3) 5.00F 0.44 (n= 5)
Fasted Triton X100R 1.00F 0.31 (n= 4) 0.30F 0.03 (n= 3)
(24 h) + Triton X100R 19.50F 1.13 (n= 4) 4.70F 0.98 (n= 3)
Values are meansF S.E.the cellular glucose 6-phosphate levels of livers from
control and arthritic rats were measured under in vivo
conditions (at 8:00 p.m.). The results are shown in Table
2. Higher hepatic cellular levels of glucose 6-phosphate
were found in both the fasted and fed states. The differ-
ence was clearly more pronounced, however, in the fasted
state.4. Discussion
Pathogenic alterations in the activity and properties of
liver glucose 6-phosphatase are not uncommon. Besides the
Type I glycogen storage disease (von Gierke’s disease),
which in its classical form is characterized by an almost total
lack of glucose 6-phosphatase activity [20], several con-
ditions are known in which this enzyme is increased. In
diabetes, the activity of glucose 6-phosphatase is increased
several times [21]. Kinetic investigations of the enzyme of
alloxan-diabetic rats revealed several structural and func-
tional alterations [22]. Increases have also been reported as a
consequence of glucocorticoid treatment of rats [23], after
Ehrlich ascites tumour development in mice [24] and in rats
bearing the Walker-256 carcinoma [25,26]. The diminished
activity of glucose 6-phosphate in adjuvant-induced arthritic
rats characterized in this study can be considered as a partial
deficiency for which several examples have already been
reported in humans [27–29].
The kinetic characteristics of the enzyme from arthritic
rats indicates a diminution of the hydrolase activity rather
than a diminution of glucose 6-phosphate translocation
across the microsomal membrane. Mainly two observations
strongly support this view. The first one concerns the fact
that both Vmax and KM were decreased in arthritic rats.
This is an expected phenomenon if the hydrolase activity
is decreased without a corresponding change in the trans-
locase activity as demonstrated by Arion et al. [10,30]
using glucose as an inhibitor. This compound inhibits the
hydrolase and is without effect on the translocase activity.
In intact microsomes, the KM for glucose 6-phosphate
hydrolysis is a complex parameter that reflects not only
the catalytic step but also permeation of the microsomal
membrane. The absence of limitation of the catalytic step
by membrane permeation reduces the apparent KM, i.e., the
extramicrosomal glucose 6-phosphate concentration that
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observation in agreement with a reduction in the hydrolase
activity in arthritic rats is the absence of stimulation of
glucose 6-phosphatase hydrolysis when hepatic micro-
somes of those rats were treated with Triton X100R. In
microsomes from control rats, Triton X100R treatment
produced the known modest increase in glucose 6-phos-
phatase hydrolysis, characterized by an increase in Vmax
and a decrease in KM [31]. The latter finding suggests that
translocation is rate-limiting in microsomes of control rats,
but that no such limitation exists in microsomes from
arthritic rats. It should be recalled that the Vmax/KM ratios
were higher in the arthritic condition. This may be indicat-
ing a more perfect coupling between translocation and
intramicrosomal hydrolysis, with a reduced limitation of
the hydrolytic process by translocation. In this sense, one
can visualize the arthritic enzyme as possessing a higher
catalytic efficiency, even though this results in a lower
hydrolytic activity. When the enzyme from control rats
was treated with Triton X100R, the Vmax/KM ratio also
increased. In this case, the catalytic efficiency increased
along with the hydrolytic activity, because Triton X100R
treatment increased permeation and abolished the limita-
tion imposed by the translocase.
The mannose 6-phosphatase activity in intact micro-
somes (no detergent treatment) was not significantly
higher in microsomes of arthritic rats. This observation
excludes the possibility of an unspecific permeation due
to damaged membranes. Furthermore, the mannose 6-
phosphatase activity of detergent-treated hepatic micro-
somes of arthritic rats was only one fourth of that one
found in microsomes from control rats, another indication
that the hydrolase activity is substantially diminished in
the pathogenic state.
Reduction of the hydrolase activity in arthritic rats could
be the result of reduced synthesis in the same way as in-
creased hydrolase activity in diabetes results from increased
synthesis [32]. Even in diabetes, however, there are other
factors affecting the activity of glucose 6-phosphatase, as for
example, the altered lipid environment of the enzyme in the
endoplasmic reticulum membrane [23]. Alterations in the
lipid environment in arthritic rats have been suggested by
several studies. Reduced synthesis of phospholipids has been
found in the liver of arthritic rats, especially phosphatidyl-
choline and phosphatidylethanolamine [33,34]. Addition-
ally, a decreased percentage of arachidonic acid present in
plasma membrane, microsomal membrane and bile canal-
icular membrane has been found [33]. These alterations have
been suggested to contribute to the impaired drug metabo-
lism in arthritic rats [34]. The question that arises is whether
these alterations could be contributing to the reduced glucose
6-phosphatase activity. It is unlikely that changes in mem-
brane composition alone could produce the rather drastic
reduction in the hydrolase activity that amounts to 75% if
one takes into account the reduction in mannose 6-phosphate
hydrolysis. However, the enzyme depends markedly on themembrane environment for its catalytic activity and, con-
sequently, it is also unlikely that changes in this environment
will be without some influence. Alterations in energy acti-
vation (Ea) are very frequently caused by structural and
environmental alterations, especially when lipidic structures
are involved [14]. The temperature dependence of Vmax in
the range between 13 and 37 jC, as revealed by the
Arrhenius plots, was not significantly changed. The activa-
tion energies (Ea) obtained from these plots are similar to
those previously reported for the same temperature range
[31,35]. Structural alterations can thus not be inferred from
the Vmax values.
The question if the reduced activity of glucose 6-phos-
phatase in arthritic rats has a physiological meaning receives
a positive answer from those experiments in which the
hepatic cellular levels of glucose 6-phosphate were meas-
ured in vivo. Higher hepatic cellular glucose 6-phosphate
levels are indeed an expected phenomenon when the activity
of glucose 6-phosphatase is reduced [36]. Glucose 6-phos-
phate is not only an important metabolic intermediate, but
also an important signalling substance [36]. It must be added
that livers from arthritic rats also present higher activities of
glucokinase [6], a condition that can equally contribute to
higher hepatic cellular glucose 6-phosphate concentrations.
Furthermore, blood glucose levels of arthritic rats are 20%
lower and the isolated perfused liver from arthritic rats
presents a strong tendency toward a reduction in glucose
release [5,37] and increased rates of lactate plus pyruvate
production from exogenous glucose [6]. All these observa-
tions, which indicate that arthritis has a marked influence on
hepatic carbohydrate metabolism, are forming a coherent
picture with the reduced glucose 6-phosphatase activity.
However, attempts of understanding the precise roles of
the altered glucose 6-phosphatase and glucokinase activities
in arthritic rats must take into account the fact that both
enzymes are heterogeneously distributed along the hepatic
acinus. Glucokinase predominates in the perivenous area
[38] whereas glucose 6-phosphatase is more concentrated in
the periportal area [39]. If this unequal distribution is
maintained in arthritic rats is not known, but it is reasonable
to suppose that heterogenic enzyme distributions also pro-
duce heterogenic metabolite distributions, including glucose
6-phosphatase. Obviously, only simultaneous measurements
of enzyme activities and metabolite concentrations along the
hepatic acinus can provide the necessary information for a
full understanding of the real meaning of the altered
glucokinase and glucose 6-phosphate activities in arthritic
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